Effective identification of cognitive impairment in primary care assisted by tablet-based digital cognitive testing
Authors:
- Alexander HankeAHAlexander Hanke
- Cornelia McCormickCornelia McCormick
- Carolin RosendahlCRCarolin Rosendahl
- Judith TillmannJudith Tillmann
- Kristin RolkeKRKristin Rolke
- Florian SchweizerFlorian Schweizer
- Leon NissenLeon Nissen
- Lara ReimerLara Reimer
- Stephan JonasStephan Jonas
- Philipp SchaperPhilipp Schaper
- Jochen René ThyrianJochen René Thyrian
- Klaus WeckbeckerKWKlaus Weckbecker
Open Access
- 15 October 2026
- journal article
- Published by SAGE Publications in Journal of Alzheimer’s Disease
Abstract
Background: Timely recognition of cognitive impairment and Alzheimer's disease (AD) is crucial for providing appropriate care to elderly individuals affected by these conditions. Digital short tests may help general practitioners (GPs) make more targeted referrals to specialists. Objective: We studied the real-world effectiveness of a referral pathway including the digital Montreal Cognitive Assessment (MoCA Duo), administered by medical assistants (MAs) in general practitioner (GP) offices, to identify mild or major neurocognitive impairment. Ancillary studies examined the procedure's feasibility, usability, and barriers in the care pathway. Methods: Ten GPs participated, one or two MAs per practice administered the MoCA Duo to patients with cognitive concerns. Patients with likely or questionable impairment were offered a referral to a memory clinic (MC) if deemed clinically appropriate. At the MC, patients received a comprehensive neuropsychological examination and a geriatric assessment. Results: Of the 299 patients tested in GP practices (mean age: 73; 65% female), 100 achieved MoCA Duo scores in the presumably unimpaired range. 93 patients (46.73%) scoring below 27 points were referred to the MC; of those, 66 attended an appointment. 40 patients had major cognitive impairment, including 9 diagnosed with AD or vascular dementia, and 15 had mild cognitive impairment (MCI). 83.33% of patients who screened positive on the MoCA Duo at the GP practice and were assessed at the MC had at least MCI. Conclusions: Digital tests administered by MAs can help to effectively screen for cognitive impairment in primary care, supporting targeted referrals of patients with likely cognitive impairment.Keywords
Funding Information
- Bundesministerium für Gesundheit (ZMII2-2523FEP40)
- University of Bonn (Open Access Publication Fund)
This publication has 31 references indexed in Scilit:
- Hürden im Versorgungspfad der Demenzdiagnostik: Framework-Analyse des Projektes „iCreate“Zeitschrift für Gerontologie und Geriatrie, 2025
- Enhancing early detection of cognitive impairment in primary care with the TabCAT‐BHAAlzheimer's & Dementia, 2025
- Subjective cognitive decline: Memory complaints, cognitive awareness, and metacognitionAlzheimer's & Dementia, 2024
- Remote and unsupervised digital memory assessments can reliably detect cognitive impairment in Alzheimer's diseaseAlzheimer's & Dementia, 2024
- Cognitive impairment and depression: Meta-analysis of structural magnetic resonance imaging studiesNeuroImage: Clinical, 2021
- Are subjective memory complaints indicative of objective cognitive decline or depressive symptoms? Findings from the English Longitudinal Study of AgeingJournal of Psychiatric Research, 2019
- Das Praxispersonal im Kontext der hausärztlichen Demenzerkennung – ein ungehobenes Potenzial?Zeitschrift für Gerontologie und Geriatrie, 2018
- Traits of patients who screen positive for dementia and refuse diagnostic assessmentAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2015
- Who refuses the diagnostic assessment for dementia in primary care?International Journal of Geriatric Psychiatry, 2006
- “Mini-mental state”Journal of Psychiatric Research, 1975